2Nd European Headache and Migraine Trust INTERNATIONAL CONGRESS - EHMTIC
Total Page:16
File Type:pdf, Size:1020Kb
2nd European Headache and Migraine Trust INTERNATIONAL CONGRESS - EHMTIC Nice, France October 28–31, 2010 ABSTRACT BOOK Co-Chairmen H-C. Diener, Germany P.J. Goadsby, UK International Scientific Advisory Committee F. Antonaci, Italy A. Charles, USA M. Ferrari, The Netherlands R. Jensen, Denmark Z. Katsarava, Germany M. Lanteri-Minet, France R. Lipton, USA J. Pascual, Spain J. Schoenen, Belgium S. Silberstein, USA D. Valade, France M.M. Wysocka-Bakowska, Poland 123 J Headache Pain (2010) 11 (Suppl 1):S1–S150 DOI 10.1007/s10194-010-0259-3 10 over between groups was realized. The frequency and the intensity of Outcome of vitamin C supplementation on lead-induced headache as well as the amount of drug intake were registered on a standardized diary from three months before the implant until the end of apoptosis in adult rat hippocampus follow-up. Quality of life was measured using a dedicated scale (SF_36 e MIDAS) at -3 0-1-3-6-12 months follow-up.34 patients have been 1 2 3 M. Mehdizade , F. Kermanian , I. Nourmohamadi enrolled in this study.After 1 year follow-up our results demonstrate a significant reduction in headache frequency (56%) and intensity (from 1Department of Anatomical Sciences, Iran University of Medical 7.8 to 5.8 in Visual analogic scale): drugs intake reduced (): media from Sciences, Molecular and Research Center, Tehran, Iran; 45 to 11 intakes for month) till then MOH changed in original primary 2Department of Anatomical Sciences, Mashhad University of Medical headache (100% migraine without aura (1.1 ICHD-II).; chronic Sciences, Mashhad, Iran; migraine (1.5.1 ICHD-II) became too migraine without aura (1.1 ICHD- 3Department of Biochemistry, Iran University of Medical Sciences, II). Adverse events were light and completely reversible. Tehran, Iran Background Lead (Pb), due to its numerous industrial applications has caused widespread pollution of the environment. One principle 17 target for lead in the human body is the central nervous system (CNS). Wolff’s extracranial vascular theory of migraine: Research has shown however that the toxic effects of lead can be moderated by antioxidant agents such as vitamin C. a great story confirmed by the facts Objective To investigate the protective effects of vitamin C supple- mentation against lead induced apoptosis in the adult male rat E. Shevel hippocampus. Design, time and setting Animal experiment, including light and The Headache Clinic, Johannesburg, South Africa electron microscopic staining and western blot analysis, was per- formed in the College of Medicine, Iran University between Objectives To clarify the role of extracranial vasodilatation in December 2007 and April 2009. migraine, and to expose the distortions and misrepresentations in the Materials Lead (Pb) was used for toxication and Vit C was use as an literature concerning this subject. antioxidant drug and Bax and Bcl-2 were used as primary antibodies. Background There has over the years been a considerable amount of Methods Animals were divided into three groups; control, Lead controversy over whether the vascular component of migraine pain treated, Lead + Vit C-treated group) rats. They treated for 7 days. arises from the intracranial or the extracranial vessels, or both. Some Main outcome measure At the end of treatment, blood Lead level have even questioned whether vasodilatation actually plays a signif- was measured. Neuronal death was determined using light and elec- icant role in migraine pain, and have described it as an unimportant tron microscopic staining and western blot analysis epiphenomenon. The controversy is an artificial one though, which Results Lead + Vit C treatment reduced neuronal apoptosis com- has been generated as a consequence of misrepresentation of the facts pared to Lead treated rats. There were decrease of Bax expression in in the headache literature. the hippocampus of Lead + Vit C group compared to Lead group in Methods The literature on the subject is extensively researched for western blotting. Changes in blood Lead level was not significant in verifiable hard scientific data on the subject. three groups. Results There have been blatant distortions in the literature with Conclusion The results suggest that supplementing essential nutrient regard to the role of extracranial vasodilatation in migraine. There is a vitamin C may prevent lead-induced apoptosis. plethora of hard scientific evidence to show that extracranial vaso- dilatation is important in migraine. Conclusions There have been significant distortions and misrepre- sentations in the literature, which have led many headache specialist 15 to believe, erroneously, that extracranial vasodilatation is not Suboccipital neurostimulation in chronic headache: important in migraine. The hard scientific evidence shows that a prospective, randomized with cross over study (i) vasodilatation is indeed a source of pain in migraine, (ii) that this dilatation does not involve the intracranial vasculature, F. Marchioretto1, G. Serra2 (iii) that the extracranial terminal branches of the external carotid artery are a source of pain in migraine. 1Headache Center, Negrar, Italy; 2Anthalgic Therapy Service, Ospedale Sacro Cuore, Negrar, Italy Patients affected by chronic headache experience a significant reduc- 20 tion in quality of life. No effective treatments are today available for this Endothelium dependent vasodilatation in migraine condition We performed a prospective, randomized study to evaluate patients safety and efficacy of bilateral suboccipital neurostimulation in patients with chronic migraine (CM) and medication overuse headache (MOH). Patients with CM and MOH were enrolled in a single Hospital headache D. Perko, M. Zaletel, B. Zvan, J. Pretnar-Oblak Center by a neurologist with experience in headache. In a preliminary phase, after signed informed consent, stimulators (Medtronic Synergy Vascular Neurology, University Clinical Centre Ljubljana, Versitrel) were provisionally implanted as an external device. After Ljubljana, Slovenia 30 days, if attack frequency was reduced C50%, neurostimulator was subcutaneously implanted. Patients were randomized into treatment Although endothelial dysfunction might be an important feature (ON stimulator) or control (OFF stimulator) groups. At week 4 cross- involved in the pathophysiology of migraine, it has been 123 J Headache Pain (2010) 11 (Suppl 1):S1–S150 S3 investigated only in a few studies. The obtained conflicting results play an important role as a causative factor. Gabapentin and Local did not provide definitive answer on the presence of endothelial injection of trigger points with corticosteroids are noted to be effec- dysfunction in migraine patients. We sought to explore flow-medi- tive in prophylactic treatment of (CTTH). ated dilatation (FMD) in migraine patients. By employing strict Materials and methods We selected CTTH patients who had active inclusion criteria we avoided the possible changes of FMD by trigger point in the head and divided them in two groups of De- confounding factors, that could produce previously obtained con- pomedrol and Gabapentin. Depomedrol was injected 10 mg per each flicting results. Forty-two patients with migraine (female 34, male 8) TrPt up to total dose of 40 mg in each patient. Gabapentin was and twenty-one healthy subjects matched by gender and age were initiated with 200 mg/day and gradually increased to 300-600 mg included. All patients had normal values of intima-media thickness daily. of carotid arteries and did not have diseases known to affect Results Headache Intensity 9 Duration index showed marked endothelial function. FMD of brachial arteries were measured by decrease in both groups. It was significantly lower in Depomedrol using standard procedure. We did not find any difference in FMD receiving patients at the end of first (368.13 ± 195.75 Vs between patients with migraine and healthy subjects (p = 0.78). 467.73 ± 203.09, P \ 0.05) and second months (165.44 ± 62.75Vs Also no differences were found between group of healthy subjects, 238.68 ± 81.39 P \ 0.05). similar superiority was detectable for migraine with aura and migraine without aura (p = 0.92) nor Intensity, Duration and Frequency of headaches. between group of migraine with and without aura (p = 0.76). We Conclusion We found trigger point injection more potent in com- found that FMD is not impaired in migraine patients, neither in parison to daily Gabapentin. This superiority was statistically those with nor without aura (p [ 0.05). Thus, it could be convinc- significant after 4 weeks and continued up to 8th week. It should be ingly concluded systemic endothelial function are not altered during noted that trigger point injection was more effective to decrease all the interictal period, but migraine could be associated with cerebral aspects of headache including intensity, duration and frequency. endothelial dysfunction. Keywords Chronic tension-type headache, Depomedrol, Trigger point, Gabapentin, Prophylactic 24 Orthostatic headache revealing multiple periradicular 26 cysts Blood-patch: immediate effective remedy for headaches secondary to dura mater injury J.A. Elosegi, C. Cuvelier, M. Rinkowski, Y. Khayat, C. Neugroschl, J.M. Gerard M.A. Hachimi Neurology, Hopital Ambroise Pare, Mons, Belgium Mohammed V, Mekne`s, Morocco Spontaneous postural headache was observed in a 49 years old Objective The aim of this study was to evaluate if bed rest during 2 h woman. MRI of the brain showed a Chairi I like aspect of the pos- in a supine posture is required to improve the efficacy